- EMPLOYEE
PARTICIPANTS - 8
- TOTAL
RATINGS
- EMPLOYEE
PARTICIPANTS - 4
- TOTAL
RATINGS
Guy Gecht vs Matt Silva
Electronics for Imaging vs inviCRO, LLC CEO Comparison Summary
Employees at Electronics for Imaging rank Guy Gecht in the Bottom 5% of CEOs in San Francisco. Comparatively, employees at inviCRO, LLC rank Matt Silva in the Top 50% of CEOs in Boston. Employees rate their CEO differently based on the frequency of interaction, ability to affect company culture, and drive measurable results.
CEO of Electronics for Imaging
BIO: Mr. Guy Gecht has been the Chief Executive Officer of Electronics For Imaging, Inc. since January 1, 2000 and has been its President since May 11, 2012. Mr. Gecht serves as Chief Executive Officer of Efi at Prism Group Holdings Pty. Ltd. Mr. Gecht serves as the Chief Executive Officer of Electronics For Imaging Ventures. From July 1999 to January 2000, Mr. Gecht served as the President of Electronics For Imaging Inc. From January 1999 to July 1999, he served as Vice President and General Manager of Server Products. From October 1995 to January 1999, he served as a Director of Software Engineering. He served as a Director of Engineering at Interro Systems from 1993 to 1995. From 1991 to 1993, he served as Software Manager of ASP Computer Products and from 1990 to 1991 he served as Manager of Networking Systems for Apple Israel. From 1985 to 1990, he served as an officer in the Israeli Defense Forces, managing an engineering development team and later was an acting manager of one of the IDF high-tech departments. He has been a Director of Electronics For Imaging, Inc. since 2000. He has been an Independent Director at Check Point Software Technologies Ltd. since 2006. Mr. Gecht holds a B.S. in Computer Science and Mathematics from Ben Gurion University in Israel.
CEO of inviCRO, LLC
BIO: Matt is CEO of Invicro and leads the strategic vision and mission to support the the drug discovery and development community. Matt holds a PhD in Biomedical Engineering from Worcester Polytechnic Institute and brings 17 years of diverse imaging experience from pharmaceutical and contract research organizations. Prior to Invicro, he was Senior Director of Translational Biology at Vertex Pharmaceuticals, where he ran the imaging and histopathology groups. Previously, he led imaging groups at Amgen, Millennium and Takeda Pharmaceuticals, focusing on the broad use of imaging biomarkers to support drug discovery and development.